|
The yet2.com global technology marketplace lists intellectual property, technology, and patents for technology transfer, technology licensing, patent licensing and patent sale. As premier technology brokers, yet2.com offers this essential IP marketplace for technology owners, technology seekers, and technology brokers interested in technology acquisition, patent licensing, intellectual property licensing (IP licensing), and intellectual property transfer.
more...
|
| This is an abstract of a technology that is available for sale or license. yet2.com can introduce you confidentially to the owner of this technology. |
| To view the complete TechPak, please register with us. |
 |
| Enter a keyword or phrase below, and search now to find other technologies of interest. |
|
|
|
|
 |
| Biomedical Center in Moscow, Russia has developed a peptide formulation that induces activation and proliferation of the cytotoxic lymphocyte's (CTL) clones and enables them to recognize and selectively kill Listeria infected cells. As the life time of CTL clones is very long (3-7 years and more) the formulation could be used for both prophylaxis and treatment. Single/double injections (application) are needed for Listeriosis' prophylaxis. Developed preparation may be used for Listeriosis treatment in combination with antibiotics and without (currently under development). The developer is looking for support/collaboration to implement following three stages: (I) promoting of the peptide preparation as a veterinarian vaccine (with therapeutic effect); (II) promoting of the peptide preparation as human vaccine (with therapeutic effect); (III) promoting of the peptide preparation in Europe and other markets. |
|
|
 |
|
Interested? This is an abstract of a technology that is available for sale or license. yet2.com can introduce you confidentially to the owner of this technology.
|
|
To view the complete TechPak, please register with us.
|
|
|
|
